GFAP and Anxiety: The interaction of mirtazapine with chronic stress produces sex-specific neurobiological outcomes-enhancing GFAP and astrocyte activation in females, potentially exacerbating anxiety-related behaviors, while reducing glutamate receptor levels and improving stress resilience in males, leading to anxiolytic effects.